BridgeMD
New treatment option for Tooth Loss
Official title Influence of Healing Time on the Outcomes of Alveolar Ridge Preservation in Periodontally Compromised Extraction Sockets
ClinicalTrials.gov ID: NCT06654141
What this study is testing
- What it's testing
- The goal of this clinical trial is to histologically, clinically, and radiographically evaluate the healing sequelae of periodontally compromised extraction sockets grafted with Bio-Oss Collagen® at 3 and 6 months following tooth extraction in molar sites. The main question it aims to answer is: Does healing time influence the histologic, clinical, and radiographic outcomes following socket grafting (alveolar ridge preservation) in periodontally compromised extraction sockets.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- ASA (American Society of Anesthesia) status I or II
- Need for molar extraction due to periodontal disease with or without chronic endodontic involvement, complying with the presentation of periodontitis...
- Radiographic evidence of a bone dehiscence on at least one socket wall, where the height of the horizontal (suprabony) component of the defect...
- Radiographic evidence of at least 3 mm of residual bone wall height
You likely can't join if
- Extraction of multiple adjacent teeth
- Acute infection associated with the tooth to be extracted or with adjacent teeth
- Current smokers (\>10 cigarettes per day)
- Uncontrolled diabetes mellitus (HbA1c \>7.0)
- Any active oral or systemic acute infections
- Currently receiving chemo- or radiotherapy or a history of radiotherapy in the head and neck area
See the full eligibility criteria
- 18 years of age or older
- ASA (American Society of Anesthesia) status I or II
- Need for molar extraction due to periodontal disease with or without chronic endodontic involvement, complying with the presentation of periodontitis stage III/IV
- Radiographic evidence of a bone dehiscence on at least one socket wall, where the height of the horizontal (suprabony) component of the defect (alveolar bone crest - cement-enamel junction) is \>50% of the corresponding...
- Radiographic evidence of at least 3 mm of residual bone wall height
- Presence of at least one adjacent tooth to the extraction site
- Treatment plan must include tooth replacement with an implant-supported fixed dental prosthesis
- Extraction of multiple adjacent teeth
- Acute infection associated with the tooth to be extracted or with adjacent teeth
- Current smokers (\>10 cigarettes per day)
- Uncontrolled diabetes mellitus (HbA1c \>7.0)
- Any active oral or systemic acute infections
- Currently receiving chemo- or radiotherapy or a history of radiotherapy in the head and neck area
- Diseases or medications that may compromise normal wound healing
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.